UNSPSC 51453303: Sulbentine

This classification denotes an antifungal agent with the molecular formula C17H18N2S2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier D0NR12WK9J, chemically known as 3,5-dibenzyltetrahydro-2h-1,3,5-thiadiazine-2-thione but more generally known as dibenzthion, which bears U.S. NIH Compound Identifier 67686. European Medicines Agency schedules Sulbentine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10678MIG.

The term SULBENTINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 22, No. 10, 1968, List 8). World Health Organization schedules dibenzthion in its Anatomical Therapeutic Chemical (ATC) Classification and its WHO-DD or Drug Dictionary.

UNSPSC 51453303 Sulbentine is a Commodity code that in recent state and local solicitations designates pharmaceutical and medical supply procurement, though the code's nominal product name does not align with the actual scope of work being bought. State and local buyers under this code are procuring naloxone (opioid reversal medication), safe drug deactivation systems, generic multi-source pharmaceuticals, over-the-counter products, and medical and first aid supplies for emergency response and public health programs. Issuing bodies include county health departments (Seminole County, Florida), state health and human services agencies (Texas Health and Human Services Commission), fire departments and rescue divisions (City of Tampa Fire Department), and cooperative purchasing alliances serving multiple state and local jurisdictions (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP). The mix reflects both single-jurisdiction procurement and multi-state cooperative purchasing vehicles designed to aggregate demand across participating entities.

Recent activity spans Florida, Texas, Minnesota, and Oregon. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026 (response due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, designating the procurement as potentially FEMA-funded with fixed-fee pricing and a two-year term plus one-year renewal option. The City of Tampa issued IFB 26P00145 on March 25, 2026 for medical and first aid supplies (169 line items) to the Tampa Fire Department Rescue Division, estimated at $700,000, with a one-year award period and two optional renewals, restricted to certified Small Local Business Enterprises with a 5% bid discount capped at $10,000. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026 to gather vendor capabilities for a Therapeutic Pharmacy Initiative direct-to-manufacturer prescriptions program. MMCAP issued RFP S1070000015802 on January 20, 2026 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products serving state and local facilities in Minnesota and Oregon through three authorized wholesalers, with awards effective July 1, 2026, a two-year term, and evaluation weighted 75 percent on price competitiveness.